Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous ...

Everolimus TFOS is indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex (TSC) for the treatment of Subependymal Giant Cell Astrocytoma (SEGA), a rare ...

Oligodendrocytes are important cells for the regeneration of myelin sheath and axons. To ensure myelin regeneration, oligodendrocyte progenitor cells must migrate from the demyelinating area of the ...

RESULTS Of the 21 subjects, 15 had isolated frontal horn cysts and six had additional ultrasound scan abnormalities, including four with subependymal haemorrhage. The sonographic features of frontal ...

Glioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of ...

Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex (“TSC”) for the treatment of subependymal giant cell astrocytoma ...

are indicated only for tuberous sclerosis complex–associated subependymal giant cell astrocytoma in adult and pediatric patients aged ≥ 1 year. The original Novartis product carries the same ...

Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex ("TSC") for the treatment of subependymal giant cell ...

Telangana: Natco Pharma has announced the resignation of Dr Pavan Ganapati Bhat as Director & Executive Vice President ...

The central nervous system (CNS), composed of the brain, spinal cord, and retina, has a limited capacity to spontaneously regenerate and this, coupled with few regenerative strategies available ...